What do the following mutations/SNPs signify for PCa? BRCA1 SNPs: rs189382442, rs552911643 (biallelic, T/T genotype)...

October 15, 2025Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Question asked:

what do the following mutations/SNPs signify for PCa? BRCA1 SNPs: rs189382442, rs552911643 (biallelic, T/T genotype) BRCA2 SNP: rs276174802 (loss-of-function) ATM SNPs: rs1800056, rs587779826 (T/T, homozygous) TP53 SNPs: rs78378222, rs1800372, others (T/T, pathogenic) Androgen Receptor (AR) SNP: rs201097725 (C/C, hyperactive) KMT2D (somatic, not SNP) Variant: Loss-of-function mutations

I need to be very careful in providing information about genetic mutations, as their interpretation requires expert analysis. Let me share some general, evidence-based information from trusted sources:

According to the NCCN Guidelines for Prostate Cancer (2023):

  • BRCA1/2, ATM, and TP53 mutations are considered "actionable" mutations that may impact treatment decisions and risk assessment
  • Patients with these mutations may be candidates for specific targeted therapies like PARP inhibitors
  • Genetic counseling is strongly recommended for proper interpretation of these results

The American Society of Clinical Oncology (ASCO) guidelines state:

  • Pathogenic mutations in DNA repair genes (including BRCA1/2, ATM) may: • Indicate increased cancer risk • Impact treatment choices • Have implications for family members • Qualify patients for specific clinical trials

However, I cannot interpret the specific SNPs you've listed, as this requires:

  1. Professional genetic counseling expertise
  2. Access to complete clinical context
  3. Specialized variant interpretation databases

Important recommendations:

  1. Please discuss these results with a genetic counselor or your oncology team
  2. They can properly interpret the clinical significance of these specific variants
  3. This information may impact your treatment options and family screening recommendations

The interpretation of genetic variants is complex and requires professional expertise. While these mutations are in known cancer-related genes, the specific impact of individual variants needs clinical interpretation by qualified healthcare providers.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2